Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways

Cisplatin is currently used to treat inoperable recurrent meningiomas, but its side effects and drug resistance limit its use. Metformin has recently been identified as a chemosensitizing agent. However, the combined treatment of cisplatin and metformin in high-grade meningiomas has not been reporte...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Oncolytics
Main Authors: Guo, Liemei, Cui, Jing, Wang, Herui, Medina, Rogelio, Zhang, Shilei, Zhang, Xiaohua, Zhuang, Zhengping, Lin, Yingying
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Gene & Cell Therapy 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851485/
https://ncbi.nlm.nih.gov/pubmed/33575476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.11.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares